Ellevest, Inc. Agios Pharmaceuticals, Inc. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$19.51 - $34.14 $156 - $273	8 New	8 $0
Q2 2022 Jul 18, 2022	SELL	$17.06 - $31.42 $119 - $219	-7 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$26.68 - $34.81 $186 - $243	7 New	7 $0
Q2 2020 Jul 06, 2020	SELL	$34.45 - $53.48 $1,722 - $2,674	-50 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$31.52 - $53.81 $1,576 - $2,690	50 New	50 $2,000
Q3 2019 Oct 08, 2019	SELL	$32.4 - $49.58 $550 - $842	-17 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$46.17 - $68.1 $784 - $1,157	17 New	17 $1,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.